Abstract
Children with sickle cell anemia treated with hydroxyurea at 2 years of age maintain Hb F levels above 20% for 4 to 6 years with little hematologic toxicity and no increased risks of infection. Its ability to prevent subclinical organ damage, however, is yet to be proven.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2228 |
| Number of pages | 1 |
| Journal | Blood |
| Volume | 106 |
| Issue number | 7 |
| DOIs | |
| State | Published - Oct 2005 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology